Intestinal Diseases  >>  Duvyzat (givinostat)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Duvyzat (givinostat) / Italfarmaco
NCT00792740 / 2007-000189-19: Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease

Terminated
1/2
51
Europe
ITF2357, Givinostat, Placebo
Italfarmaco
Crohn's Disease
12/08
03/09

Download Options